Giulia Negrini

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma

Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra et al. · Journal of Hepatology · 2017 · 111 citations · Full text

Medicine, Infectious Diseases, Hepatology +14

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale

Andrea Casadei‐Gardini, Luca Faloppi, Serena De Matteis et al. · European Journal of Cancer · 2017 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients

Francesco Tovoli, Luca Ielasi, Andrea Casadei‐Gardini et al. · Journal of Hepatology · 2019 · 84 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten‐free diet: beyond traditional metabolic factors

Francesco Tovoli, Giulia Negrini, Roberto Farì et al. · Alimentary Pharmacology & Therapeutics · 2018 · 78 citations · Full text

Medicine, Internal Medicine, Nutrition +17

Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib

Francesco Tovoli, Matteo Renzulli, Giulia Negrini et al. · European Radiology · 2018 · 66 citations

Medicine, Oncology, Tumor Progression +13